Ocuphire Pharma, Inc. is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Ocuphire Pharma plans to initiate several Phase 3 programs across multiple clinical trials as well as a potential NDA approval.
Social Media Links
REPORT RATINGS
4.8 / 5.0 (116)
Ocuphire Pharma, Inc. reports have an aggregate usefulness score of 4.8 based on 116 reviews.